Media Room

For Immediate Release

Truven Health Analytics Links Clinical Data with Claims to Enhance Oncology Outcomes Research

Linking claims data with detailed clinical data allows oncology researchers to capture the total patient journey including both treatment and costs in more defined patient populations

Ann Arbor, MI, Jul. 22, 2014 — Truven Health Analytics™ today announced it has successfully linked electronic medical records (EMR) and administrative claims data with significant volume to power oncology-focused outcomes research studies. This de-identified data set, the newest addition to the MarketScan® Research Databases, provides a unique ability for researchers to better understand total healthcare costs, co-morbidities, adverse events, and outcomes for cancer patients by treatment phase, biomarker status, and tumor stage.

“It is exciting to see the pace of development for break-through oncology treatments. As these products come to market, researchers require real-world data to conduct high quality investigations that demonstrate the value of these new treatments.” said Stacey Long, vice president and general manager at Truven Health Analytics. “Payers, providers, and patients want to understand how new treatments affect not only health outcomes, but also overall costs. To do this, researchers need patient-level data that include not only the robust clinical data offered by an oncology EMR, but also the same patient’s claims data to understand associated healthcare costs and the full spectrum of a patient’s care beyond that provided by their oncologist. We are delighted to be able to offer this ground-breaking capability to the healthcare research community.”

The new MarketScan Oncology EMR-Claims Data Set contains de-identified healthcare and cost data for over 50, 000 unique patients who have undergone cancer treatment in the past three years. Using these data, researchers are now able to conduct analytical projects that explore treatment decisions and outcomes for specific patient sub-populations, such as those defined by cancer stage or biomarker test. In addition, researchers will be able to understand the full continuum of healthcare provided to these patients and the associated costs.

“New research-ready data sources are essential for answering real world research questions aimed at getting the right treatment to the right patient at the right time, ” said Kathleen Foley, senior director of strategic consulting at Truven Health Analytics. “The new MarketScan Oncology EMR-Claims Data Set broadens our ability to address important policy issues related to the development and evaluation of new payment mechanisms such as bundling. In addition, questions about treatment sequencing within rapidly changing treatment paradigms and the impact of treatment choices on outcomes and costs can be addressed.”

For over two decades, researchers from government, industry, and academia have relied on the MarketScan Research Databases to analyze the cost of care, evaluate the effectiveness of medical treatments, understand prescription drug utilization patterns, and research other important healthcare issues. These databases include de-identified healthcare claims data reflecting the real-world medical care of over 200 million unique U.S. patients since 1995.

For more information on Truven Health oncology research solutions, click here

About Truven Health Analytics, part of the IBM Watson Health Business

Truven Health Analytics®, part of the IBM Watson Health™ business, provides market-leading performance improvement solutions built on data integrity, advanced analytics and domain expertise. For more than 40 years, our insights and solutions have been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies and policymakers, the facts they need to make confident decisions that directly affect the health and well-being of people and organizations in the US and around the world. The company was acquired by IBM in 2016 to help form a new business, Watson Health. Watson Health aspires to improve lives and give hope by delivering innovation to address the world’s most pressing health challenges through data and cognitive insights.

Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan®, 100 Top Hospitals®, Advantage Suite®, Micromedex®, Simpler® and ActionOI®. Truven Health has its principal offices in Ann Arbor, MI, Chicago, IL, and Denver, CO.


Brian Erni
For Truven Health Analytics
J. Roderick, Inc. Public Relations